Invention Grant
- Patent Title: Compounds for treating TNBC
-
Application No.: US16621896Application Date: 2018-06-13
-
Publication No.: US11413276B2Publication Date: 2022-08-16
- Inventor: Thomas Jorg Mehrling
- Applicant: PURDUE PHARMA L.P.
- Applicant Address: US CT Stamford
- Assignee: PURDUE PHARMA L.P.
- Current Assignee: PURDUE PHARMA L.P.
- Current Assignee Address: US CT Stamford
- Agency: McCarter & English, LLP
- Agent Yu Lu
- Priority: GB1709406 20170613
- International Application: PCT/EP2018/065662 WO 20180613
- International Announcement: WO2018/229130 WO 20181220
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; A61P35/00 ; A61K9/00 ; A61K31/502 ; A61K45/06
Abstract:
There is provided tinostamustine or a pharmaceutically acceptable salt thereof for use in the treatment of triple negative breast cancer (TNBC) to a patient in need thereof.
Public/Granted literature
- US20200230109A1 COMPOUNDS FOR TREATING TNBC Public/Granted day:2020-07-23
Information query
IPC分类:
